Reducing 30-Day Sepsis Readmissions: Impact of a Post Discharge Education Program

NCT05602896 | Withdrawn

• 1 other identifier: 202207066
• Study Type: interventional
• Target: N/A
• Locations: 0 countries
• Sites: N/A

Brief Summary

This study will advance the knowledge in the field by determining the effectiveness of discharge education regarding prevention of a new infection which is the highest cause of readmission for sepsis patient. In evaluating the impact care teams will develop a clearer link between specific home-based education interventions and infection prevention. This study is an exploratory study designed to identify whether patient education through an innovative teaching method can have an impact on readmissions. This study may the first of several based on findings from this initial, exploratory study.

Conditions

Sepsis

Keywords

sepsis; education; cancer

Outcome Measures

Primary Outcomes (1)

• Readmission rates

  4 months

Study Arms (1)

Sepsis Education

EXPERIMENTAL

The patient will receive a daily notification via their mobile phone and conduct the daily activity for 30 days. The program is interactive and aimed at measures that prevent exposure to infection sources in the environment, as well as recognition of early signs of infection and possible sepsis. Each session takes approximately 2 minutes or less. Each scenario or session has the user identify where germs may be present and then asks the user to perform a simple action to remove the germs (e.g. with an antiseptic wipe). The range of activities include cleaning of surfaces, proper mask use, and hand sanitizing. This includes areas of their home such as the kitchen, bathroom, living room/family room. The program also addresses common community areas such as public transit, grocery stores, and restaurants

Other: Sepsis education

Interventions

Sepsis education OTHER

The education program has been reviewed and approved by BJH Center for Practice Excellence

Sepsis Education

Eligibility Criteria

• Age: 18 Years - 85 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Oncology patients discharged to home following a diagnosis of sepsis, severe sepsis or septic shock
• Patient must have a mobile phone/device
• English speakers
• Age range 18 - 85 years

You may not qualify if:

• Less than 18 years of age and older than 85 years of age
• No mobile phone/device
• Non-English speaking
• No diagnosis of sepsis, severe sepsis, or septic shock
• Non-Oncology patient

Sponsors & Collaborators

• Washington University School of Medicine: lead
• BJC HealthCare: collaborator
• Viven Health: collaborator

Related Links

• Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

MeSH Terms

Conditions

Sepsis; Neoplasms

Condition Hierarchy (Ancestors)

Infections; Systemic Inflammatory Response Syndrome; Inflammation; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Nancy Bickel, MSN, APRN, ANCP-BC, ACNS-BC

  BJC HealthCare

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 27, 2022
• First Posted: November 2, 2022
• Study Start: March 31, 2024
• Primary Completion: July 31, 2025
• Study Completion: July 31, 2025
• Last Updated: June 14, 2024

Record last verified: 2024-06

Data Sharing

• IPD Sharing: Will not share